Bone Support

Share Price

BONEX 296.00 SEK

+2.07%

09:47:00 CET Fri May 09 2025

  • Contact Us
Follow
  • US site
    • Global English Site
    • Global Swedish Site
    • US site
  • Bonesupport
    • Message from the CEO
    • Vision & Mission
    • Sustainability
    • History
    • Management
    • The Board
    • Our Partners
    • Careers
  • Products
    • CERAMENT® BONE VOID FILLER
    • CERAMENT® G with Gentamicin
    • Reimbursement Programs
    • OPTIONAL DELIVERY DEVICES
  • Innovation
    • Current Technology
    • Pipeline
    • CERTiFy Clinical Trial
  • Indications
  • Medical Professionals
  • Investors
  • Patients
    • Bone Grafts
    • BONE DEFECTS CAUSED BY TRAUMA
    • BONE DEFECTS CAUSED BY BENIGN BONE TUMORS
    • BONE DEFECTS CAUSED BY HIP AND KNEE REVISIONS
  • Events
  • Media
    • Press Releases
    • Publications and Resources
    • Multimedia
    • Media Archive
  • Financials
  • Financial Reports
  • Presentations
  • The Share
  • Analyst Coverage
  • Shareholders
  • Corporate Governance
  • Calendar
  • Q&A
  • Definitions
  • Capital Markets Day 2022
  • CAPITAL MARKETS DAY 2023

Financial Reports 2021

BONESUPPORT HOLDING AB was listed on Nasdaq Stockholm on 21st June 2017 and interim reports are published from Q2 2017.

PDF Icon

Full year report 2021

17/02/2022

Net sales increased by 15 percent (21 percent at constant exchange rates) and amounted to SEK 61.4 million (53.2). The gross margin amounted to 89.3 percent (89.8). Operating result amounted to SEK -21.8 million (-26.7).
PDF Icon

Interim Report, Q3, January – September 2021

04/11/2021

Net sales increased by 14 percent (26 percent at constant exchange rates) and amounted to SEK 54.9 million (48.1). The gross margin amounted to 89.0 percent (91.4). Operating result amounted to SEK -13.3 million (-19.2).
PDF Icon

Interim Report, Q2, January – June 2021

15/07/2021

Net sales increased by 43 percent (58 percent at constant exchange rates) and amounted to SEK 51.8 million (36.2). The gross margin amounted to 89.5 percent (86.7). Operating result amounted to SEK -25.9 million (-23.5).
PDF Icon

Interim Report, Q1, January – March 2021

06/05/2021

Net sales increased by 3 percent (14 percent at constant exchange rates) and amounted to SEK 44.8 million (43.4). The gross margin amounted to 88.6 percent (88.7). Operating result amounted to SEK -19.7 million (-29.2).

©BONESUPPORT AB 2025. ALL RIGHTS RESERVED. CERAMENT and BONESUPPORT are registered Trademarks of BONESUPPORT AB.

  • Home
  • Contact Us
  • Privacy Policy
  • Cookie Policy